Growth factor activation in myocardial vascularization: Therapeutic implications

Molecular and Cellular Biochemistry

Volumn 264, Issue 1-2, 2004, Pages 3-11

  Tomanek, Robert J ^a,b   Zheng, Wei ^a,b   Yue, Xinping ^a,b  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

Angiopoietins; bFGF; Hypoxia; Shear stress; Stretch; VEGF

Indexed keywords

3,5 DIIODOTHYROPROPIONIC ACID; ADENOSINE DERIVATIVE; ALCOHOL; ALINIDINE; ANGIOGENIC FACTOR; ANGIOGENIN; ANGIOPOIETIN 1; BASIC FIBROBLAST GROWTH FACTOR; DIPYRIDAMOLE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FIBROBLAST GROWTH FACTOR 2; HYPOXIA INDUCIBLE FACTOR 1; HYPOXIA INDUCIBLE FACTOR 2ALPHA; INTERLEUKIN 1ALPHA; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; NITRIC OXIDE; OXYGEN; RECOMBINANT TRANSFORMING GROWTH FACTOR BETA; SOMATOMEDIN C; THYROXINE; THYROXINE DERIVATIVE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VASCULOTROPIN; VASCULOTROPIN A; VASCULOTROPIN B; VASCULOTROPIN C; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2; XANTHINE DERIVATIVE;

ADAPTATION; ANGIOGENESIS; AUTOCRINE EFFECT; BRADYCARDIA; CAPILLARY PROLIFERATION; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY COLLATERAL CIRCULATION; GENE DELIVERY SYSTEM; GENE EXPRESSION REGULATION; GENE THERAPY; GROWTH REGULATION; HEART DEVELOPMENT; HEART HYPERTROPHY; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE METABOLISM; HEART MUSCLE OXYGEN CONSUMPTION; HUMAN; HYPOXIA; ISCHEMIC HEART DISEASE; KINESIOTHERAPY; MECHANICAL STIMULATION; MUSCLE STRETCHING; MYOTATIC REFLEX; NONHUMAN; PARACRINE SIGNALING; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SHEAR STRESS;

ANIMALS; ANOXIA; CORONARY VESSELS; FIBROBLAST GROWTH FACTOR 2; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GROWTH SUBSTANCES; HEART; HUMANS; MODELS, BIOLOGICAL; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; SIGNAL TRANSDUCTION; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 5544312225     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:MCBI.0000044369.88528.a3     Document Type: Review

References (81)

1. Hudlicka O, Brown M, Egginton S: Angiogenesis in skeletal and cardiac muscle. Physiol Rev 72: 369-417, 1992
2. Adair TH, Gay WJ, Montani JP: Growth regulation of the vascular system: Evidence for a metabolic hypothesis. Am J Physiol 259: R393-R404, 1990
3. Schaper W: New paradigms for collateral vessel growth. Basic Res Cardiol 88: 193-198, 1993
4. Tomanek RJ, Sandra A, Zheng W, Brock T, Bjercke RJ, Holifield JS: Vascular endothelial growth factor and basic fibroblast growth factor differentially modulate early postnatal coronary angiogenesis. Circ Res 88: 1135-1141, 2001
5. Tomanek RJ, Zheng W, Peters KG, Lin P, Holifield JS, Suvarna PR: Multiple growth factors regulate coronary embryonic vasculogenesis. Dev Dyn 221: 265-273, 2001
6. Ikuta T, Ariga H, Matsumoto KI: Effect of tenascin-X together with vascular endothelial growth factor A on cell proliferation in cultured embryonic hearts. Biol Pharm Bull 24: 1320-1323, 2001
7. Lagercrantz J, Farnebo F, Larsson C, Tvrdik T, Weber G, Piehl F: A comparative study of the expression patterns for vegf, vegf-b/vrf and vegf-c in the developing and adult mouse. Biochim Biophys Acta 1398: 157-163, 1998
8. Makinen T, Olofsson B, Karpanen T, Hellman U, Soker S, Klagsbrun M, Eriksson U, Alitalo K: Differential binding of vascular endothelial growth factor B splice and proteolytic isoforms to neuropilin-1. J Biol Chem 274: 21217-21222, 1999
9. Lymboussaki A, Olofsson B, Eriksson U, Alitalo K: Vascular endothelial growth factor (VEGF) and VEGF-C show overlapping binding sites in embryonic endothelia and distinct sites in differentiated adult endothelia. Circ Res 85: 992-999, 1999
10. Tomanek RJ, Holifield JS, Reiter RS, Sandra A, Lin JJ: Role of VEGF family members and receptors in coronary vessel formation. Dev Dyn 225: 233-240, 2002
11. Tomanek RJ, Ratajska A, Kitten GT, Yue X, Sandra A: Vascular endothelial growth factor expression coincides with coronary vasculogenesis and angiogenesis. Dev Dyn 215: 54-61, 1999
12. Tomanek RJ, Hu N, Phan B, Clark EB: Rate of coronary vascularization during embryonic chicken development is influenced by the rate of myocardial growth. Cardiovasc Res 41: 663-671, 1999
13. Tomanek RJ, Haung L, Suvarna PR, O'Brien LC, Ratajska A, Sandra A: Coronary vascularization during development in the rat and its relationship to basic fibroblast growth factor. Cardiovasc Res 31 Spec No.: E116-E126, 1996
14. Tomanek RJ: Formation of the coronary vasculature: A brief review. Cardiovasc Res 31 Spec No.: E46-E51, 1996
15. Luttun A, Tjwa M, Carmeliet P: Placental growth factor (PIGF) and its receptor Flt-1 (VEGFR-1): Novel therapeutic targets for angiogenic disorders. Ann New York Acad Sci 979: 80-93, 2002
16. Iyer S, Acharya KR: Role of placenta growth factor in cardiovascular health. Trends Cardiovasc Med 12: 128-134, 2002
17. Ziche M, Maglione D, Ribatti D, Morbidelli L, Lago CT, Battisti M, Paoletti I, Barra A, Tucci M, Parise G, Vincenti V, Granger HJ, Viglietto G, Persico MG: Placenta growth factor-1 is chemotactic, mitogenic, and angiogenic. Lab Invest 76: 517-531, 1997
18. Pipp F, Heil M, Issbrucker K, Ziegelhoeffer T, Martin S, van den Heuvel J, Weich H, Fernandez B, Golomb G, Carmeliet P, Schaper W, Clauss M: VEGFR-1-selective VEGF homologue PIGF is arteriogenic: Evidence for a monocyte-mediated mechanism. Circ Res 92: 378-385, 2003
19. Felmeden DC, Blann AD, Lip GY: Angiogenesis: Basic pathophysiology and implications for disease. Eur Heart J 24: 586-603, 2003
20. Salven P, Hattori K, Heissig B, Rafii S: Interleukin-1 alpha promotes angiogenesis in vivo via VEGFR-2 pathway by inducing inflammatory cell VEGF synthesis and secretion. FASEB J 16: 1471-1473, 2002
21. Koolwijk P, van Erck MG, de Vree WJ, Vermeer MA, Weich HA, Hanemaaijer R, van Hinsbergh VW: Cooperative effect of TNFalpha, bFGF, and VEGF on the formation of tubular structures of human microvascular endothelial cells in a fibrin matrix. Role of urokinase activity. J Cell Biol 132: 1177-1188, 1996
22. Gale NW, Yancopoulos GD: Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development. Genes Dev 13: 1055-1066, 1999
23. Rossant J, Howard L: Signaling pathways in vascular development. Annu Rev Cell Dev Biol 18: 541-573, 2002
24. Visconti RP, Richardson CD, Sato TN: Orchestration of angiogenesis and arteriovenous contribution by angiopoietins and vascular endothelial growth factor (VEGF). Proc Natl Acad Sci USA 99: 8219-8224, 2002
25. Seghezzi G, Patel S, Ren CJ, Gualandris A, Pintucci G, Robbins ES, Shapiro RL, Galloway AC, Rifkin DB, Mignatti P: Fibroblast growth factor-2 (FGF-2) induces vascular endothelial growth factor (VEGF) expression in the endothelial cells of forming capillaries: An autocrine mechanism contributing to angiogenesis. J Cell Biol 141: 1659-1673, 1998
26. Adair TH, Guyton AC, Montani JP, Lindsay HL, Stanek KA: Whole body structural vascular adaptation to prolonged hypoxia in chick embryos. Am J Physiol 252: H1228-H1234, 1987
27. Tomanek RJ, Lund DD, Yue X: Hypoxic induction of myocardial vascularization during development. In: R.C. Roach et al. (eds). Hypoxia: Through the Life Cycle. Kluwer Academic Press/Plenum Publishers, New York (in press)
28. Ryan HE, Lo J, Johnson RS: HIF-1 alpha is required for solid tumor formation and embryonic vascularization. Embo J 17: 3005-3015, 1998
29. Maxwell PH, Ratcliffe PJ: Oxygen sensors and angiogenesis. Semin Cell Dev Biol 13: 29-37, 2002
30. Levy AP: Hypoxic regulation of VEGF mRNA stability by RNA-binding proteins. Trends Cardiovasc Med 8: 246-250, 1998
31. Mie Lee Y, Kim SH, Kim HS, Jin Son M, Nakajima, H, Jeong Kwon H, Kim KW: Inhibition of hypoxia-induced angiogenesis by FK228, a specific histone deacetylase inhibitor, via suppression of HIF-1alpha activity. Biochem Biophys Res Commun 300: 241-246, 2003
32. Forsythe JA, Jiang BH, Iyer NV, Again F, Leung SW, Koos RD, Semenza GL: Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 16: 4604-4613, 1996
33. Li J, Shworak NW, Simons M: Increased responsiveness of hypoxic endothelial cells to FGF2 is mediated by HIF-1alpha-dependent regulation of enzymes involved in synthesis of heparan sulfate FGF2-binding sites. J Cell Sci 115: 1951-1959, 2002
34. Wahlander H, Haraldsson B, Friberg P: Myocardial capillary diffusion capacity in rat hearts with cardiac hypertrophy due to pressure and volume overload. Am J Physiol 265: H61-H68, 1993
35. Carabello BA, Nakano K, Ishihara K, Kanazawa S, Biederman RW, Spann JF Jr.: Coronary blood flow in dogs with contractile dysfunction due to experimental volume overload. Circulation 83: 1063-1075, 1991
36. Gascho JA, Mueller TM, Eastham C, Marcus ML: Effect of volume-overload hypertrophy on the coronary circulation awake dogs. Cardiovasc Res 16: 288-292, 1982
37. Legault F, Rouleau JL, Juneau C, Rose C, Rakusan K: Functional and morphological characteristics of compensated and decompensated cardiac hypertrophy in dogs with chronic infrarenal aorto-caval fistulas. Circ Res 66: 846-859, 1990
38. Chen Y, Torry RJ, Baumbach GL, Tomanek RJ: Proportional arteriolar growth accompanies cardiac hypertrophy induced by volume overload. Am J Physiol 267: 112132-112137, 1994
39. Poupa O, Rakusan K, Ostadal B: The effect of physical activity upon the heart of the vertebrates. Med Sport 4: 202-235, 1970
40. Mattfeldt T, Mall G: Growth of capillaries and myocardial cells in the normal rat heart. J Mol Cell Cardiol 19: 1237-1246, 1987
41. Hudlicka O, Brown MD: Postnatal growth of the heart and its blood vessels. J Vasc Res 33: 266-287, 1996
42. Hudlicka O, Brown MD, Walter H, Weiss JB, Bate A: Factors involved in capillary growth in the heart. Mol Cell Biochem 147: 57-68, 1995
43. Brown MD, Davies MK, Hudlicka O: The effect of long-term bradycardia on heart microvascular supply and performance. Cell Mol Biol Res 40: 137-142, 1994
44. Wright AJ, Hudlicka O: Capillary growth and changes in heart performance induced by chronic bradycardial pacing in the rabbit. Circ Res 49: 469-478, 1981
45. Zheng W, Brown MD, Brock TA, Bjercke RJ, Tomanek RJ: Bradycardia-induced coronary angiogenesis is dependent on vascular endothelial growth factor. Circ Res 85: 192-198, 1999
46. Hudlicka O, Wright AJ, Hoppeler H, Uhlmann E: The effect of chronic bradycardial pacing on the oxidative capacity in rabbit hearts. Respir Physiol 72: 1-12, 1988
47. Lei L, Christensen LP, Zhou R, Tomanek RJ: Induction of chronic bradycardia after infarction upregulates bFGF and VEGF and myocardial angiogenesis. Circulation 106: II-215, 2002
48. Li J, Hampton T, Morgan JP, Simons M: Stretch-induced VEGF expression in the heart. J Clin Invest 100: 18-24, 1997
49. Seko Y, Takahashi N, Shibuya M, Yazaki Y: Pulsatile stretch stimulates vascular endothelial growth factor (VEGF) secretion by cultured rat cardiac myocytes. Biochem Biophys Res Commun 254: 462-465, 1999
50. Zheng W, Seftor EA, Meininger CJ, Hendrix MJ, Tomanek RJ: Mechanisms of coronary angiogenesis in response to stretch: Role of VEGF and TGF-beta. Am J Physiol Heart Circ Physiol 280: H909-H917, 2001
51. Hudlicka O, Brown MD: Physical forces and angiogenesis. In: G.M. Rubanyi (eds). Mechanoreception by the Vascular Wall. Futura Publishing Co. Inc., Mount Kisko, NY, 1993, pp 197-241.
52. Tomanek RJ, Torry RJ: Growth of the coronary vasculature in hypertrophy: Mechanisms and model dependence. Cell Mol Biol Res 40: 129-136, 1994
53. Mall G, Mattfeldt T, Volk B: Ultrastructural morphometric study on the rat heart after chronic ethanol feeding. Virchows Arch A Pathol Anat Histol 389: 59-77, 1980
54. Tornling G: Capillary neoformation in the heart and skeletal muscle during dipyridamole-treatment and exercise. Acta Pathol Microbiol Immunol Scand Suppl 278: 1-63, 1982
55. Ziada AM, Hudlicka O, Tyler KR, Wright AJ: The effect of long-term vasodilatation on capillary growth and performance in rabbit heart and skeletal muscle. Cardiovasc Res 18: 724-732, 1984
56. Granger HJ, Ziche M, Hawker JR Jr, Meininger CJ, Czisny LE, Zawieja DC: Molecular and cellular basis of myocardial angiogenesis. Cell Mol Biol Res 40: 81-85, 1994
57. Ziche M, Morbidelli L, Choudhuri R, Zhang HT, Donnini S, Granger HJ, Bicknell R: Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis. J Clin Invest 99: 2625-2634, 1997
58. Papapetropoulos A, Garcia-Cardena G, Madri JA, Sessa WC: Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells. J Clin Invest 100: 3131-3139, 1997
59. Papapetropoulos A, Desai KM, Rudic RD, Mayer B, Zhang R, Ruiz-Torres MP, Garcia-Cardena G, Madri JA, Sessa WC: Nitric oxide synthase inhibitors attenuate transforming-growth-factor-beta 1-stimulated capillary organization in vitro. Am J Pathol 150: 1835-1844, 1997
60. Pipili-Synetos E, Sakkoula E, Haralabopoulos G, Andriopoulou P, Peristeris P, Maragoudakis ME: Evidence that nitric oxide is an endogenous antiangiogenic mediator. Br J Pharmacol 111: 894-902, 1994
61. Skalak TC, Price RJ: The role of mechanical stresses in microvascular remodeling. Microcirculation 3: 143-165, 1996
62. Langille BL: Remodeling of developing and mature arteries: Endothelium, smooth muscle, and matrix. J Cardiovasc Pharmacol 21: S11-S17, 1993
63. Laughlin MH, McAllister RM: Exercise training-induced coronary vascular adaptation. J Appl Physiol 73: 2209-2225, 1992
64. Laughlin MH, Oltman CL, Bowles DK: Exercise training-induced adaptations in the coronary circulation. Med Sci Sports Exerc 30: 352-360, 1998
65. Crisman RP, Rittman B, Tomanek RJ: Exercise-induced myocardial capillary growth in the spontaneously hypertensive rat. Microvasc Res 30: 185-194, 1985
66. Tomanek RJ: Exercise-induced coronary angiogenesis: A review. Med Sci Sports Exerc 26: 1245-1251, 1994
67. Waltenberger J: Modulation of growth factor action: Implications for the treatment of cardiovascular diseases. Circulation 96: 4083-4094, 1997
68. Losordo DW, Vale PR, Symes JF, Dunnington CH, Esakof DD, Maysky M, Ashare AB, Lathi K, Isner JM: Gene therapy for myocardial angiogenesis: Initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia. Circulation 98: 2800-2804, 1998
69. Sellke FW, Ruel M: Vascular growth factors and angiogenesis in cardiac surgery. Ann Thorac Surg 75: S685-S690, 2003
70. Isner JM: Myocardial gene therapy. Nature 415: 234-239, 2002
71. Morishita R, Aoki M, Kaneda Y, Ogihara T: Gene therapy in vascular medicine: Recent advances and future perspectives. Pharmacol Ther 91: 105-114, 2001
72. Simons M, Bonow RO, Chronos NA, Cohen DJ, Giordano FJ, Hammond HK, Laham RJ, Li W, Pike M, Sellke FW, Stegmann TJ, Udelson JE, Rosengart TK: Clinical trials in coronary angiogenesis: Issues, problems, consensus: An expert panel summary. Circulation 102: E73-E86, 2000
73. Kornowski R, Fuchs S, Leon MB, Epstein SE: Delivery strategies to achieve therapeutic myocardial angiogenesis. Circulation 101: 454-458, 2000
74. van Royen N, Piek JJ, Buschmann I, Hoefer I, Voskuil M, Schaper W: Stimulation of arteriogenesis; a new concept for the treatment of arterial occlusive disease. Cardiovasc Res 49: 543-553, 2001
75. Yu AY, Shimoda LA, Iyer NV, Huso DL, Sun X, McWilliams R, Beaty T, Sham JS, Wiener CM, Sylvester JT, Semenza GL: Impaired physiological responses to chronic hypoxia in mice partially deficient for hypoxia-inducible factor 1alpha. J Clin Invest 103: 691-696, 1999
76. Tomanek RJ, Schatteman GC: Angiogenesis: New insights and therapeutic potential. Anat Rec 261: 126-135, 2000
77. Wang X, Zheng W, Christensen LP, Tomanek RJ: DITPA stimulates bFGF, VEGF, angiopoietin, and Tie-2 and facilitates coronary arteriolar growth. Am J Physiol Heart Circ Physiol 284: H613-H618, 2003
78. Mahaffey KW, Raya TE, Pennock GD, Morkin E, Goldman S: Left ventricular performance and remodeling in rabbits after myocardial infarction. Effects of a thyroid hormone analogue. Circulation 91: 794-801, 1995
79. Hoit BD, Pawloski-Dahm CM, Shao Y, Gabel M, Walsh RA: The effects of a thyroid hormone analog on left ventricular performance and contractile and calcium cycling proteins in the baboon. Proc Assoc Am Physicians 109: 136-145, 1997
80. Schaper W: The Collateral Circulation of the Heart. Amsterdam, London. Elsevier North Holland Publishing Company, 1971
81. Zheng W, Weiss RM, Wang X, Zhou R, Arlen A, Lei L, Lazartiques E, Tomanek RJ: DITPA stimulates arteriolar growth and modifies myocardial post infarction remodeling. Am J Physiology 286: H1994-H2000, 2004